Corvus Pharmaceuticals, Inc. Public Float
Corvus Pharmaceuticals, Inc. (CRVS) had Public Float of $251.90 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $251.90M.
- 2024-06-30: Entity Public Float $69.00M.
- 2023-06-30: Entity Public Float $84.20M.
- 2022-06-30: Entity Public Float $34.20M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $251.90M 10-K · filed 2026-03-12 |
| 2024-06-30 | $69.00M 10-K · filed 2025-03-25 |
| 2023-06-30 | $84.20M 10-K · filed 2024-03-19 |
| 2022-06-30 | $34.20M 10-K · filed 2023-03-28 |
| 2021-06-30 | $65.00M 10-K · filed 2022-03-10 |
| 2020-06-30 | $43.80M 10-K · filed 2021-03-25 |
| 2019-06-30 | $65.70M 10-K · filed 2020-03-09 |
| 2018-06-30 | $156.70M 10-K · filed 2019-03-07 |
| 2017-06-30 | $102.80M 10-K · filed 2018-03-01 |
| 2016-06-30 | $118.60M 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Apnimed, Inc. (APMD) | United States | $0.899B |